Skip to main content
Fig. 3 | BMC Endocrine Disorders

Fig. 3

From: Comparing the efficacy of thyroglobulin and thyroglobulin/ thyroid-stimulating hormone ratio models in predicting a successful response to radioactive iodine therapy

Fig. 3

Receiver-operating characteristic (ROC) curves of the thyroglobulin [A: cutoff = 3.40 ng/mL (area under the curve: 0.789) with 63.4% sensitivity and 84.0% specificity] and regarding thyroglobulin/thyroid-stimulating hormone ratio [B: cutoff = 36.03 ng/mIU (area under the curve: 0.788) with 67.2% sensitivity and 81.5% specificity] as predictors of successful radioiodine therapy

Back to article page

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us